Clarix Imaging

About Clarix Imaging

Clarix Imaging specializes in bringing true 3D clarity to specimen imaging, particularly for breast surgical oncology. Their mission is to enhance visualization of lumpectomy specimen margins with unprecedented clarity using innovative technology to benefit patients and physicians.

Products & Services

VSI-360™:An intraoperative volumetric specimen imaging system specialized for breast surgical oncology. It provides True 3D image reconstruction of specimens, allowing direct visualization of the entire volume and high-resolution tissue slices without overlapping tissue obscuring margins.

Specialties

Breast Surgical Oncology Volumetric Specimen Imaging 3D Imaging Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 10000000 MR: - FA: 10 million FAN: 10000000	D: 2023-10-04 FD: 2023-10-04	1 investors

Debt Latest

2023-10-04

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Lester

Senior Software Engineer

B

Bidur Bohara

Senior Scientist

M

Melissa Nielsen

Clinic Application Specialist

L

Li Lan

Senior Software Engineer

G

Gopal Mohanty

VP of Regulatory/Quality

X

Xiao Han

CEO & Co-Founder

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Clarix Imaging Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised